PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+15.12%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$60.7M
AUM Growth
+$60.7M
(-53%)
Cap. Flow
-$74.1M
Cap. Flow
% of AUM
-122.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
3
Closed
1
Top Buys
| 1 |
Pulmatrix
PULM
|
$2 |
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$11.4M |
| 2 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$112K |
| 3 |
Dare Bioscience
DARE
|
$3 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Fate Therapeutics
FATE
$120M
| $34.2M | 56.34% | 854,836 -284,947 | -25% | -$11.4M |
|
2
Lyra Therapeutics
LYRA
$11.5M
| $12.3M | 20.29% | 1,100,852 | – | – |
|
3
Cartesian Therapeutics
RNAC
$261M
| $6.88M | 11.34% | 2,773,479 | – | – |
|
4
Neuronetics
STIM
$220M
| $3.56M | 5.87% | 732,583 | – | – |
|
5
X4 Pharmaceuticals
XFOR
$84.2M
| $2.11M | 3.48% | 311,492 | – | – |
|
|
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
| $452K | 0.75% | 197,345 -48,733 | -20% | -$112K |
|
|
7
Pulmatrix
PULM
$18M
| $428K | 0.71% | 359,441 +2 | +0% | +$2 |
|
|
ATYR
8
aTyr Pharma
ATYR
$527M
| $422K | 0.7% | 130,572 | – | – |
|
|
9
Dare Bioscience
DARE
$27.2M
| $326K | 0.54% | 326,240 -3 | -0% | -$3 |
|